Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: Past and Future Roles of 5-HT4 Receptor Agonists

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 27-36

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis, pharmacology and therapeutic potential of 10-methoxypyrazino[1,2-a]indoles, partial agonists at the 5HT 2C receptor

By Bos M.   Jenck F.   Martin J.   Moreau J.   Mutel V.   Sleight A.   Widmer U.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 3, 1997-01 ,pp. : 253-261

Elsevier

Access to resources Recommend Favorite

5-HT3 Serotonin Receptor Agonists: A Pharmacophoric Journey

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 2, 2004-06 ,pp. : 77-94

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin 5-HT Receptor Agonists as Antidepressants: Pharmacological Rationale and Evidence for Efficacy

By Heiser J.F.   Wilcox C.S.  

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 343-353

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 1, Iss. 2, 2001-08 ,pp. : 171-199

Bentham Science Publishers

Access to resources Recommend Favorite